I acknowledge that I have read the Privacy Policy

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support


Physician Dispensed Cosmeceuticals Market was valued at USD 8.5 Billion in 2021, and USD 9.16 billion in 2022 and it is expected to reach a value of USD 16.7 Billion by 2030, at a CAGR of 7.8% over the forecast period (2023 - 2030).

The Global Physician Dispenced Cosmeceuticals market is relatively fragmented, with a high level of competition. Companies are working on new product launches and other initiatives to provide better equipment to their customers and expand their companies globally. These industry leaders are expanding their client base in a variety of ways, and many organizations are forming strategic and creative partnerships with other start-up businesses in order to increase market share and profitability. Due to the existence of numerous small and major producers, the market is somewhat competitive. Due to increased expenditures in R&D for product innovation and boosting product efficiency by bringing new items into the market, the market rivalry is fierce. Allergan, Merz Pharma, INNOVATIVE SKINCARE, Obagi Cosmeceuticals LLC, SkinCeuticals International, and others are key participants in the industry. 'Allergan Plc', 'SkinMedica, Inc.', 'Biopelle, Inc.', 'Clinique Laboratories, LLC', 'Cutera, Inc.', 'Emerson Ecologics, LLC', 'iS CLINICAL', 'Jan Marini Skin Research, Inc.', 'La Roche-Posay Laboratoire Pharmaceutique', 'Neutrogena Corp.', 'Obagi Medical Products, Inc.', 'SkinCeuticals', 'Stiefel Laboratories, Inc.'

The need for cosmeceuticals to eliminate visible aging indications is driven by a rise in personal maintenance awareness among the elderly population and changing views among the middle-aged and aging population in emerging nations.

SkinCeuticals, a pioneer in breakthrough skincare technologies, will launch Vivace Fractional Micro Needle Radio Frequency Procedure with SkinCeuticals C E Ferulic in October 2020, a minimally invasive skin rejuvenation treatment.

North America, Europe, Asia Pacific, and the Rest of the World make up the Global Physician Dispensed Cosmeceuticals Market. Over the projected period, the Asia Pacific market is predicted to increase considerably. In the area, there is a growing desire to see long-lasting young appearance and beauty, which is driving the demand for effective physician-dispensed cosmeceuticals. Furthermore, the Asia Pacific market will be driven by leading market players' increasing focus on expansion in Asia Pacific nations, the region's large consumer base, and increased awareness of physician-dispensed cosmeceuticals.

Feedback From Our Clients

Global Physician Dispensed Cosmeceuticals Market

Product ID: SQMIG35I2100